BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21646376)

  • 1. Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer.
    Borowsky AD
    Cold Spring Harb Perspect Biol; 2011 Sep; 3(9):a009670. PubMed ID: 21646376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse models of breast cancer.
    Regua AT; Arrigo A; Doheny D; Wong GL; Lo HW
    Cancer Lett; 2021 Sep; 516():73-83. PubMed ID: 34090924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary epithelial cell transformation: insights from cell culture and mouse models.
    Dimri G; Band H; Band V
    Breast Cancer Res; 2005; 7(4):171-9. PubMed ID: 15987472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
    Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
    Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.
    Muller WJ
    Cancer Metastasis Rev; 1991 Oct; 10(3):217-27. PubMed ID: 1662559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method of producing genetically manipulated mouse mammary gland.
    Tagaya H; Ishikawa K; Hosokawa Y; Kobayashi S; Ueoka Y; Shimada M; Ohashi Y; Mikami H; Yamamoto M; Ihara T; Kumazawa K; Sugihara K; Goshima N; Watanabe S; Semba K
    Breast Cancer Res; 2019 Jan; 21(1):1. PubMed ID: 30611295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models.
    Lüönd F; Bill R; Vettiger A; Oller H; Pelczar P; Christofori G
    J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):39-45. PubMed ID: 30209717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of breast cancer.
    Sakamoto K; Schmidt JW; Wagner KU
    Methods Mol Biol; 2015; 1267():47-71. PubMed ID: 25636464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of breast cancer metastasis.
    Fantozzi A; Christofori G
    Breast Cancer Res; 2006; 8(4):212. PubMed ID: 16887003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.
    McCoy EL; Iwanaga R; Jedlicka P; Abbey NS; Chodosh LA; Heichman KA; Welm AL; Ford HL
    J Clin Invest; 2009 Sep; 119(9):2663-77. PubMed ID: 19726883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical use of advanced mouse models for lung cancer.
    Safari R; Meuwissen R
    Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development.
    Greenow KR; Smalley MJ
    Curr Protoc Pharmacol; 2015 Sep; 70():14.36.1-14.36.14. PubMed ID: 26331886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
    Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
    Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.
    Hu Y; Sun H; Drake J; Kittrell F; Abba MC; Deng L; Gaddis S; Sahin A; Baggerly K; Medina D; Aldaz CM
    Cancer Res; 2004 Nov; 64(21):7748-55. PubMed ID: 15520179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation: the new challenge for pathology.
    Cardiff RD; Rosner A; Hogarth MA; Galvez JJ; Borowsky AD; Gregg JP
    Toxicol Pathol; 2004; 32 Suppl 1():31-9. PubMed ID: 15209401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models of human breast cancer.
    Cardiff RD
    Comp Med; 2003 Jun; 53(3):250-3. PubMed ID: 12868567
    [No Abstract]   [Full Text] [Related]  

  • 20. Mus tales: a hands-on view.
    Young LJ
    J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):343-9. PubMed ID: 18654840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.